Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
Buy
82
AGYS Quote, Financials, Valuation and Earnings
Last price:
$105.95
Seasonality move
:
4.79%
Day range:
$104.23 - $106.83
52-week range:
$63.71 - $142.64
Dividend yield:
0%
P/E ratio:
127.56x
P/S ratio:
10.85x
P/B ratio:
11.16x
Volume:
396.3K
Avg. volume:
297.6K
1-year change:
12.03%
Market cap:
$3B
Revenue:
$275.6M
EPS (TTM):
$0.83
Analysts' Opinion
-
Consensus RatingAgilysys has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $116.75, Agilysys has an estimated upside of 10.27% from its current price of $105.88.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $90.00 representing 100% downside risk from its current price of $105.88.
Fair Value
-
According to the consensus of 4 analysts, Agilysys has 10.27% upside to fair value with a price target of $116.75 per share.
AGYS vs. S&P 500
-
Over the past 5 trading days, Agilysys has overperformed the S&P 500 by 1.19% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Agilysys does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Agilysys has grown year-over-year revenues for 16 quarters straight. In the most recent quarter Agilysys reported revenues of $74.3M.
Earnings Growth
-
Agilysys has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Agilysys reported earnings per share of $0.14.
Enterprise value:
2.9B
EV / Invested capital:
10.06x
Price / LTM sales:
10.85x
EV / EBIT:
113.06x
EV / Revenue:
10.58x
PEG ratio (5yr expected):
0.04x
EV / Free cash flow:
55.73x
Price / Operating cash flow:
57.13x
Enterprise value / EBITDA:
86.31x
Gross Profit (TTM):
$172M
Return On Assets:
5.73%
Net Income Margin (TTM):
8.43%
Return On Equity:
9.12%
Return On Invested Capital:
8.38%
Operating Margin:
7.35%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $198.1M | $237.5M | $275.6M | $62.2M | $74.3M | |
| Gross Profit | $120.8M | $144.3M | $172M | $38.3M | $45.1M | |
| Operating Income | $13.2M | $15.8M | $23.4M | $3.5M | $5.5M | |
| EBITDA | $20.3M | $25.2M | $33.8M | $6.1M | $8.3M | |
| Diluted EPS | $0.49 | $3.16 | $0.83 | $0.11 | $0.14 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $133.3M | $136.2M | $154.7M | $188.9M | $123.5M | |
| Total Assets | $189.9M | $214.2M | $243M | $350.4M | $434.4M | |
| Current Liabilities | $61.2M | $71.5M | $78.5M | $89.4M | $111M | |
| Total Liabilities | $74.5M | $81.4M | $98.3M | $114M | $168.5M | |
| Total Equity | $115.3M | $132.8M | $144.8M | $236.5M | $265.9M | |
| Total Debt | -- | -- | -- | -- | $24M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $34.5M | $48.2M | $55.1M | $29.8M | $27.2M | |
| Cash From Investing | -$6.9M | -$7.6M | -$148.6M | $58K | -$1.5M | |
| Cash From Financing | -$11.1M | -$8.6M | $21.9M | -$1.2M | -$13.3M | |
| Free Cash Flow | $27.2M | $40.1M | $52.3M | $29.3M | $26.5M | |
AGYS
Sector
Market Cap
$3B
$79.6M
Price % of 52-Week High
74.23%
61.26%
Dividend Yield
0%
0%
Shareholder Yield
-0.1%
0.79%
1-Year Price Total Return
12.03%
-14.63%
Beta (5-Year)
0.579
0.829
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$103.68
200-day SMA
Buy
Level
$101.84
Bollinger Bands (100)
Buy
Level
68.46 - 105.38
Chaikin Money Flow
Buy
Level
6.6M
20-day SMA
Buy
Level
$89.98
Relative Strength Index (RSI14)
Buy
Level
78.10
ADX Line
Buy
Level
50.13
Williams %R
Sell
Level
-3.7631
50-day SMA
Buy
Level
$79.25
MACD (12, 26)
Buy
Level
8.23
25-day Aroon Oscillator
Buy
Level
96
On Balance Volume
Neutral
Level
46.7M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (8.6315)
Buy
CA Score
(Annual)
Level (0.7659)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (1.2567)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Agilysys Inc provides hospitality software delivering cloud-native SaaS and on-premise solutions for hotels, resorts, cruise lines, casinos, corporate foodservice management, restaurants, universities, stadiums, and healthcare facilities. The company’s software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. It derives maximum revenue from the provision of software subscription and maintenance services, followed by the provision of professional services, and the sale of products (proprietary software licenses, third-party hardware, and operating systems). Agilysys operates across North America, Europe, the Middle East, Asia-Pacific, and India.
Stock Forecast FAQ
In the current month, AGYS has received 4 Buy ratings 0 Hold ratings, and 0 Sell ratings. The AGYS average analyst price target in the past 3 months is $116.75.
-
Where Will Agilysys Stock Be In 1 Year?
According to analysts, the consensus estimate is that Agilysys share price will rise to $116.75 per share over the next 12 months.
-
What Do Analysts Say About Agilysys?
Analysts are divided on their view about Agilysys share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Agilysys is a Sell and believe this share price will drop from its current level to $90.00.
-
What Is Agilysys's Price Target?
The price target for Agilysys over the next 1-year time period is forecast to be $116.75 according to 4 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is AGYS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Agilysys is a Buy. 4 of 4 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of AGYS?
You can purchase shares of Agilysys via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Agilysys shares.
-
What Is The Agilysys Share Price Today?
Agilysys was last trading at $105.95 per share. This represents the most recent stock quote for Agilysys. Yesterday, Agilysys closed at $105.88 per share.
-
How To Buy Agilysys Stock Online?
In order to purchase Agilysys stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
